Thomas R. Johnson

3.9k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Thomas R. Johnson is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas R. Johnson has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas R. Johnson's work include Growth Hormone and Insulin-like Growth Factors (8 papers), RNA Interference and Gene Delivery (4 papers) and Animal Genetics and Reproduction (4 papers). Thomas R. Johnson is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), RNA Interference and Gene Delivery (4 papers) and Animal Genetics and Reproduction (4 papers). Thomas R. Johnson collaborates with scholars based in United States, France and Spain. Thomas R. Johnson's co-authors include Judith E. Karp, Rein Saral, Michael G. Rinaldi, John R. Wingard, William G. Merz, Joseph Ilan, Wayne O. Southwick, H. Kirk Watson, Andrew S. Kraft and Malti Nikrad and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas R. Johnson

51 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1991 774 citations John R. Wingard, William G. Merz et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas R. Johnson United States	26	1.1k	757	756	638	609	51	3.1k
Pier Giulio Conaldi Italy	34	1.3k 1.2×	609 0.8×	657 0.9×	571 0.9×	392 0.6×	173	3.6k
Renzo Boldorini Italy	37	911 0.8×	793 1.0×	770 1.0×	646 1.0×	1.8k 2.9×	242	5.3k
Moritaka Suga Japan	42	1.2k 1.1×	489 0.6×	1.0k 1.3×	323 0.5×	1.0k 1.6×	116	6.3k
Patrick A. Adegboyega United States	32	1.1k 1.0×	736 1.0×	872 1.2×	179 0.3×	634 1.0×	88	3.4k
Ashim Das India	30	774 0.7×	802 1.1×	1.5k 1.9×	718 1.1×	518 0.9×	277	3.8k
Victoria A. Ploplis United States	37	1.4k 1.2×	446 0.6×	555 0.7×	334 0.5×	339 0.6×	143	5.1k
Antonio Angeloni Italy	28	541 0.5×	206 0.3×	692 0.9×	414 0.6×	657 1.1×	149	2.2k
Ferenc Györkey United States	31	676 0.6×	777 1.0×	708 0.9×	522 0.8×	464 0.8×	114	3.5k
J N Siegel United States	27	681 0.6×	502 0.7×	661 0.9×	261 0.4×	158 0.3×	45	2.5k
Hock‐Liew Eng Taiwan	32	399 0.4×	1.1k 1.4×	1.1k 1.5×	351 0.6×	503 0.8×	166	3.3k

Countries citing papers authored by Thomas R. Johnson

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Johnson more than expected).

Fields of papers citing papers by Thomas R. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Johnson. The network helps show where Thomas R. Johnson may publish in the future.

Co-authorship network of co-authors of Thomas R. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Johnson. A scholar is included among the top collaborators of Thomas R. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Johnson. Thomas R. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Thomas R., et al.. (2025). Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids. Communications Biology. 8(1). 838–838. 2 indexed citations

Castro, Abril C., Gerardo Martínez‐Guajardo, Thomas R. Johnson, et al.. (2012). CBe5E− (E = Al, Ga, In, Tl): planar pentacoordinate carbon in heptaatomic clusters. Physical Chemistry Chemical Physics. 14(43). 14764–14764. 52 indexed citations

Su, Xin, Lihua Ao, Yi Shi, et al.. (2011). Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4. Journal of Biological Chemistry. 286(14). 12213–12220. 75 indexed citations

Mauchley, David, Xianzhong Meng, Thomas R. Johnson, et al.. (2010). Heat shock protein 27: Induction by gastroduodenal reflux in vivo and augmentation of human esophageal mucosal cell growth in vitro. Journal of Thoracic and Cardiovascular Surgery. 139(4). 1019–1025. 4 indexed citations

Mauchley, David, Xianzhong Meng, Thomas R. Johnson, David A. Fullerton, & Michael J. Weyant. (2010). Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A2. Journal of Thoracic and Cardiovascular Surgery. 139(3). 591–599. 25 indexed citations

Jokl, Peter, et al.. (2005). Implications of the Pivot Shift in the ACL-Deficient Knee. Clinical Orthopaedics and Related Research. &NA;(436). 229–236. 104 indexed citations

Nikrad, Malti, et al.. (2005). The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Molecular Cancer Therapeutics. 4(3). 443–449. 149 indexed citations

Johnson, Thomas R., Malti Nikrad, Wei‐Xing Zong, et al.. (2003). The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene. 22(32). 4953–4963. 150 indexed citations

Rowinsky, Eric K., Thomas R. Johnson, Charles E. Geyer, et al.. (2000). DX-8951f, a Hexacyclic Camptothecin Analog, on a Daily-Times-Five Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies. Journal of Clinical Oncology. 18(17). 3151–3163. 37 indexed citations

10.

Trojan, Jerzy, Thomas R. Johnson, Olivier Farges, et al.. (1995). Expression of serum albumin and of alphafetoprotein in murine normal and neoplastic primitive embryonic structures. Molecular Reproduction and Development. 42(4). 369–378. 3 indexed citations

11.

Chernicky, Cheryl L., Raymond W. Redline, Huiqing Tan, et al.. (1994). Expression of insulin‐like growth factors I and II in conceptuses from normal and diabetic mice. Molecular Reproduction and Development. 37(4). 382–390. 10 indexed citations

12.

Kelley, Kevin M., et al.. (1993). Transgenic strategies in reproductive endocrinology. Molecular Reproduction and Development. 34(3). 337–347. 3 indexed citations

13.

Trojan, Jerzy, Thomas R. Johnson, Susan D. Rudin, et al.. (1993). Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA. Science. 259(5091). 94–97. 262 indexed citations

14.

Daimon, Makoto, et al.. (1992). The third IGF‐II promoter specifies transcription of three transcripts out of five in human placenta. Molecular Reproduction and Development. 33(4). 413–417. 7 indexed citations

15.

Daimon, Makoto, et al.. (1991). Unique 3′‐untranslated sequence of insulin‐like growth factor‐I isolated from human placenta. Molecular Reproduction and Development. 29(3). 238–244. 3 indexed citations

16.

Wingard, John R., William G. Merz, Michael G. Rinaldi, et al.. (1991). Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole. New England Journal of Medicine. 325(18). 1274–1277. 774 indexed citations breakdown →

17.

Hoener, Betty‐Ann, Barry L. Engelstad, Homer A. Macapinlac, et al.. (1991). Comparison of Fe‐HBED and Fe‐EHPG as hepatobiliary MR contrast agents. Journal of Magnetic Resonance Imaging. 1(3). 357–362. 15 indexed citations

18.

Johnson, Thomas R., et al.. (1991). Effects of actinomycin D and cycloheximide on transcript levels of IGF‐I, actin, and albumin in hepatocyte primary cultures treated with growth hormone and insulin. Molecular Reproduction and Development. 30(2). 95–99. 15 indexed citations

19.

Johnson, Thomas R., et al.. (1989). Expression of Insulin-Like Growth Factor I in Cultured Rat Hepatocytes: Effects of Insulin and Growth Hormone. Molecular Endocrinology. 3(3). 580–587. 70 indexed citations

20.

Conn, Harold O., W. M. Schreiber, S. G. Elkington, & Thomas R. Johnson. (1969). Cirrhosis and diabetes. Digestive Diseases and Sciences. 14(12). 837–852. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact